Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 mRNA
1.2.3 RNA Interference (RNAi)
1.2.4 Antisense Oligonucleotide (ASO)
1.2.5 Other
1.3 Market by Application
1.3.1 Global RNA Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Therapeutics Market Perspective (2018-2029)
2.2 RNA Therapeutics Growth Trends by Region
2.2.1 Global RNA Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 RNA Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 RNA Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 RNA Therapeutics Market Dynamics
2.3.1 RNA Therapeutics Industry Trends
2.3.2 RNA Therapeutics Market Drivers
2.3.3 RNA Therapeutics Market Challenges
2.3.4 RNA Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Therapeutics Players by Revenue
3.1.1 Global Top RNA Therapeutics Players by Revenue (2018-2024)
3.1.2 Global RNA Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global RNA Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Therapeutics Revenue
3.4 Global RNA Therapeutics Market Concentration Ratio
3.4.1 Global RNA Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Therapeutics Revenue in 2022
3.5 RNA Therapeutics Key Players Head office and Area Served
3.6 Key Players RNA Therapeutics Product Solution and Service
3.7 Date of Enter into RNA Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Therapeutics Breakdown Data by Type
4.1 Global RNA Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global RNA Therapeutics Forecasted Market Size by Type (2024-2029)
5 RNA Therapeutics Breakdown Data by Application
5.1 Global RNA Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global RNA Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America RNA Therapeutics Market Size (2018-2029)
6.2 North America RNA Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America RNA Therapeutics Market Size by Country (2018-2024)
6.4 North America RNA Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Therapeutics Market Size (2018-2029)
7.2 Europe RNA Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe RNA Therapeutics Market Size by Country (2018-2024)
7.4 Europe RNA Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific RNA Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific RNA Therapeutics Market Size by Region (2018-2024)
8.4 Asia-Pacific RNA Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Therapeutics Market Size (2018-2029)
9.2 Latin America RNA Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America RNA Therapeutics Market Size by Country (2018-2024)
9.4 Latin America RNA Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa RNA Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa RNA Therapeutics Market Size by Country (2018-2024)
10.4 Middle East & Africa RNA Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna
11.1.1 Moderna Company Detail
11.1.2 Moderna Business Overview
11.1.3 Moderna RNA Therapeutics Introduction
11.1.4 Moderna Revenue in RNA Therapeutics Business (2018-2024)
11.1.5 Moderna Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Detail
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals RNA Therapeutics Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis RNA Therapeutics Introduction
11.3.4 Novartis Revenue in RNA Therapeutics Business (2018-2024)
11.3.5 Novartis Recent Development
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Detail
11.4.2 Ionis Pharmaceuticals Business Overview
11.4.3 Ionis Pharmaceuticals RNA Therapeutics Introduction
11.4.4 Ionis Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024)
11.4.5 Ionis Pharmaceuticals Recent Development
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Detail
11.5.2 Sarepta Therapeutics Business Overview
11.5.3 Sarepta Therapeutics RNA Therapeutics Introduction
11.5.4 Sarepta Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.5.5 Sarepta Therapeutics Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi RNA Therapeutics Introduction
11.6.4 Sanofi Revenue in RNA Therapeutics Business (2018-2024)
11.6.5 Sanofi Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer RNA Therapeutics Introduction
11.7.4 Pfizer Revenue in RNA Therapeutics Business (2018-2024)
11.7.5 Pfizer Recent Development
11.8 Arrowhead Pharmaceuticals
11.8.1 Arrowhead Pharmaceuticals Company Detail
11.8.2 Arrowhead Pharmaceuticals Business Overview
11.8.3 Arrowhead Pharmaceuticals RNA Therapeutics Introduction
11.8.4 Arrowhead Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024)
11.8.5 Arrowhead Pharmaceuticals Recent Development
11.9 BioNTech
11.9.1 BioNTech Company Detail
11.9.2 BioNTech Business Overview
11.9.3 BioNTech RNA Therapeutics Introduction
11.9.4 BioNTech Revenue in RNA Therapeutics Business (2018-2024)
11.9.5 BioNTech Recent Development
11.10 Orna Therapeutics
11.10.1 Orna Therapeutics Company Detail
11.10.2 Orna Therapeutics Business Overview
11.10.3 Orna Therapeutics RNA Therapeutics Introduction
11.10.4 Orna Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.10.5 Orna Therapeutics Recent Development
11.11 CRISPR Therapeutics
11.11.1 CRISPR Therapeutics Company Detail
11.11.2 CRISPR Therapeutics Business Overview
11.11.3 CRISPR Therapeutics RNA Therapeutics Introduction
11.11.4 CRISPR Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.11.5 CRISPR Therapeutics Recent Development
11.12 Silence Therapeutics
11.12.1 Silence Therapeutics Company Detail
11.12.2 Silence Therapeutics Business Overview
11.12.3 Silence Therapeutics RNA Therapeutics Introduction
11.12.4 Silence Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.12.5 Silence Therapeutics Recent Development
11.13 Astellas Pharma Inc.
11.13.1 Astellas Pharma Inc. Company Detail
11.13.2 Astellas Pharma Inc. Business Overview
11.13.3 Astellas Pharma Inc. RNA Therapeutics Introduction
11.13.4 Astellas Pharma Inc. Revenue in RNA Therapeutics Business (2018-2024)
11.13.5 Astellas Pharma Inc. Recent Development
11.14 CureVac
11.14.1 CureVac Company Detail
11.14.2 CureVac Business Overview
11.14.3 CureVac RNA Therapeutics Introduction
11.14.4 CureVac Revenue in RNA Therapeutics Business (2018-2024)
11.14.5 CureVac Recent Development
11.15 Sirnaomics
11.15.1 Sirnaomics Company Detail
11.15.2 Sirnaomics Business Overview
11.15.3 Sirnaomics RNA Therapeutics Introduction
11.15.4 Sirnaomics Revenue in RNA Therapeutics Business (2018-2024)
11.15.5 Sirnaomics Recent Development
11.16 Arcturus Therapeutics
11.16.1 Arcturus Therapeutics Company Detail
11.16.2 Arcturus Therapeutics Business Overview
11.16.3 Arcturus Therapeutics RNA Therapeutics Introduction
11.16.4 Arcturus Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.16.5 Arcturus Therapeutics Recent Development
11.17 Arbutus Biopharma
11.17.1 Arbutus Biopharma Company Detail
11.17.2 Arbutus Biopharma Business Overview
11.17.3 Arbutus Biopharma RNA Therapeutics Introduction
11.17.4 Arbutus Biopharma Revenue in RNA Therapeutics Business (2018-2024)
11.17.5 Arbutus Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global RNA Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of mRNA
Table 3. Key Players of RNA Interference (RNAi)
Table 4. Key Players of Antisense Oligonucleotide (ASO)
Table 5. Key Players of Other
Table 6. Global RNA Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global RNA Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global RNA Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global RNA Therapeutics Market Share by Region (2018-2024)
Table 10. Global RNA Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global RNA Therapeutics Market Share by Region (2024-2029)
Table 12. RNA Therapeutics Market Trends
Table 13. RNA Therapeutics Market Drivers
Table 14. RNA Therapeutics Market Challenges
Table 15. RNA Therapeutics Market Restraints
Table 16. Global RNA Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global RNA Therapeutics Market Share by Players (2018-2024)
Table 18. Global Top RNA Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Therapeutics as of 2022)
Table 19. Ranking of Global Top RNA Therapeutics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by RNA Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players RNA Therapeutics Product Solution and Service
Table 23. Date of Enter into RNA Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global RNA Therapeutics Revenue Market Share by Type (2018-2024)
Table 27. Global RNA Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global RNA Therapeutics Revenue Market Share by Type (2024-2029)
Table 29. Global RNA Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global RNA Therapeutics Revenue Market Share by Application (2018-2024)
Table 31. Global RNA Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global RNA Therapeutics Revenue Market Share by Application (2024-2029)
Table 33. North America RNA Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America RNA Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America RNA Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe RNA Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe RNA Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe RNA Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific RNA Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific RNA Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific RNA Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America RNA Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America RNA Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America RNA Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa RNA Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa RNA Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa RNA Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 48. Moderna Company Detail
Table 49. Moderna Business Overview
Table 50. Moderna RNA Therapeutics Product
Table 51. Moderna Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 52. Moderna Recent Development
Table 53. Alnylam Pharmaceuticals Company Detail
Table 54. Alnylam Pharmaceuticals Business Overview
Table 55. Alnylam Pharmaceuticals RNA Therapeutics Product
Table 56. Alnylam Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 57. Alnylam Pharmaceuticals Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis RNA Therapeutics Product
Table 61. Novartis Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Ionis Pharmaceuticals Company Detail
Table 64. Ionis Pharmaceuticals Business Overview
Table 65. Ionis Pharmaceuticals RNA Therapeutics Product
Table 66. Ionis Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 67. Ionis Pharmaceuticals Recent Development
Table 68. Sarepta Therapeutics Company Detail
Table 69. Sarepta Therapeutics Business Overview
Table 70. Sarepta Therapeutics RNA Therapeutics Product
Table 71. Sarepta Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 72. Sarepta Therapeutics Recent Development
Table 73. Sanofi Company Detail
Table 74. Sanofi Business Overview
Table 75. Sanofi RNA Therapeutics Product
Table 76. Sanofi Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. Pfizer Company Detail
Table 79. Pfizer Business Overview
Table 80. Pfizer RNA Therapeutics Product
Table 81. Pfizer Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Arrowhead Pharmaceuticals Company Detail
Table 84. Arrowhead Pharmaceuticals Business Overview
Table 85. Arrowhead Pharmaceuticals RNA Therapeutics Product
Table 86. Arrowhead Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 87. Arrowhead Pharmaceuticals Recent Development
Table 88. BioNTech Company Detail
Table 89. BioNTech Business Overview
Table 90. BioNTech RNA Therapeutics Product
Table 91. BioNTech Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 92. BioNTech Recent Development
Table 93. Orna Therapeutics Company Detail
Table 94. Orna Therapeutics Business Overview
Table 95. Orna Therapeutics RNA Therapeutics Product
Table 96. Orna Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 97. Orna Therapeutics Recent Development
Table 98. CRISPR Therapeutics Company Detail
Table 99. CRISPR Therapeutics Business Overview
Table 100. CRISPR Therapeutics RNA Therapeutics Product
Table 101. CRISPR Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 102. CRISPR Therapeutics Recent Development
Table 103. Silence Therapeutics Company Detail
Table 104. Silence Therapeutics Business Overview
Table 105. Silence Therapeutics RNA Therapeutics Product
Table 106. Silence Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 107. Silence Therapeutics Recent Development
Table 108. Astellas Pharma Inc. Company Detail
Table 109. Astellas Pharma Inc. Business Overview
Table 110. Astellas Pharma Inc. RNA Therapeutics Product
Table 111. Astellas Pharma Inc. Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 112. Astellas Pharma Inc. Recent Development
Table 113. CureVac Company Detail
Table 114. CureVac Business Overview
Table 115. CureVac RNA Therapeutics Product
Table 116. CureVac Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 117. CureVac Recent Development
Table 118. Sirnaomics Company Detail
Table 119. Sirnaomics Business Overview
Table 120. Sirnaomics RNA Therapeutics Product
Table 121. Sirnaomics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 122. Sirnaomics Recent Development
Table 123. Arcturus Therapeutics Company Detail
Table 124. Arcturus Therapeutics Business Overview
Table 125. Arcturus Therapeutics RNA Therapeutics Product
Table 126. Arcturus Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 127. Arcturus Therapeutics Recent Development
Table 128. Arbutus Biopharma Company Detail
Table 129. Arbutus Biopharma Business Overview
Table 130. Arbutus Biopharma RNA Therapeutics Product
Table 131. Arbutus Biopharma Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 132. Arbutus Biopharma Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA Therapeutics Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global RNA Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. mRNA Features
Figure 4. RNA Interference (RNAi) Features
Figure 5. Antisense Oligonucleotide (ASO) Features
Figure 6. Other Features
Figure 7. Global RNA Therapeutics Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 8. Global RNA Therapeutics Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Research Institutions Case Studies
Figure 11. RNA Therapeutics Report Years Considered
Figure 12. Global RNA Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global RNA Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global RNA Therapeutics Market Share by Region: 2022 VS 2029
Figure 15. Global RNA Therapeutics Market Share by Players in 2022
Figure 16. Global Top RNA Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by RNA Therapeutics Revenue in 2022
Figure 18. North America RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America RNA Therapeutics Market Share by Country (2018-2029)
Figure 20. United States RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe RNA Therapeutics Market Share by Country (2018-2029)
Figure 24. Germany RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific RNA Therapeutics Market Share by Region (2018-2029)
Figure 32. China RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America RNA Therapeutics Market Share by Country (2018-2029)
Figure 40. Mexico RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa RNA Therapeutics Market Share by Country (2018-2029)
Figure 44. Turkey RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Moderna Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 47. Alnylam Pharmaceuticals Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 48. Novartis Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 49. Ionis Pharmaceuticals Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 50. Sarepta Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 51. Sanofi Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 52. Pfizer Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 53. Arrowhead Pharmaceuticals Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 54. BioNTech Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 55. Orna Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 56. CRISPR Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 57. Silence Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 58. Astellas Pharma Inc. Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 59. CureVac Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 60. Sirnaomics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 61. Arcturus Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 62. Arbutus Biopharma Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed